4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0000950170-24-032990
Chief Financial Officer sold 3,524 shares at $72.69 ($256,160)
- Chief Financial Officer acquired 10,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Prasad Raju Chief Financial Officer | 2024-03-14 | Option exercise | +10,000 | 10,000 | D | ||
| Prasad Raju Chief Financial Officer | 2024-03-15 | Sale | −3,524 | $72.69 | $256,160 | 6,476 | D |
| Derivatives | |||||||
| Prasad Raju Chief Financial Officer | 2024-03-14 | Option exercise · Restricted Stock Units | −10,000 | 30,000 | D | ||
| Open-market sales · 3,524 sh · avg $72.69 · $256,160 | |||||||
Loading xslF345X05/ownership.xml…